Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)

NCT01736475 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

BIOLOGICAL: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method
BIOLOGICAL: PEGylated Recombinant Factor VIII
BIOLOGICAL: PEGylated Recombinant Factor VIII
BIOLOGICAL: PEGylated Recombinant Factor VIII

Sponsor

Baxalta now part of Shire